|
||
|
Publications
Croyle, M.A. 2009 Long-Term Virus-Induced Alterations of CYP3A-Mediated Drug Metabolism: A Look at the Virology, Immunology and Molecular Biology of a Multi-Faceted Problem Expert Opin Drug Metab Toxicol. (in press). Renteria, S. S., Clemens, C.C., Wonganan, P.W., and Croyle, M. A. Effects of Concentration and Formulation on Adenovirus Stability and Infectious Titer During Actuation from Two Intranasal Delivery Devices 2009 (in review) Wonganan, P., Clemmens, C., Leggiero, E., Brasky, K., Dekker, J., Astone, D., Pastore, L. and Croyle, M.A. Pharmacology and Toxicology of PEGylated Helper-Dependent Adenovirus in Non-Human Primates. 2009 (in review). Wonganan, P., Zamboni, W.C., Strychor, S., Dekker, J.D. and Croyle, M.A. Drug-Virus Interaction: Effect of Administration of Recombinant Adenoviruses on the Pharmacokinetics of Docetaxel in a Rat Model. 2009 Cancer Gene Therapy 16(5):405-14. Richardson, J.S., Yao, M.K., Tran, K.N., Croyle, M.A., Strong, J.E., Feldmann, H., and Kobinger, G.P. Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine. 2009 PLoS ONE. 4(4):e5308. Croyle, M., Patel, A., Tran, K., Gray, M., Zhang, Y., Strong, J., Feldmann, H., and Kobinger, G.P. Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves The Immune Response In Mice. 2008 PLoS One. 3(10):e3548. Callahan, S. M., Wonganan, P., and Croyle, M. A. Molecular and Macromolecular Alterations of Recombinant Adenoviral Vectors Do Not Resolve Changes in Hepatic Drug Metabolism During Infection. Viorlogy Journal 2008 Sept. 30 5:111 doi: 10.1186/1743-422X-5-111. Boquet, M.P., Wonganan, P., Dekker, J.D., and Croyle, M.A. Impact of Route of Systemic Administration of Adenovirus on Virus-Mediated Toxicity: Focus on Mortality, Virus Distribution, and Drug Metabolism. J. Pharmacol. Toxicol. Methods . 2008 58(3):222-32. Le, H. T., Boquet, M. P., Clark, E. A., Callahan, S. M., and Croyle, M. A. Renal Pathophysiology after Systemic Administration of Recombinant Adenovirus: Changes in Renal Cytochromes P450 Based upon Vector Dose. Hum. Gene Ther. 2006 17(11):1095-1111. Callahan, S. M., Boquet, M. P., Ming, X., Brunner, L. J. and Croyle, M. A. Impact of Transgene Expression on Drug Metabolism Following Systemic Adenoviral Vector Administration. J. Gene Med. 2006 8(5):566-576. Callahan, S. M., Ming, X., Lu, S. K., Brunner, L. J. and Croyle, M. A. Considerations for Use of Recombinant Adenoviral Vectors: Dose Effect on Hepatic Cytochromes P450. J. Pharmacol. Exp. Ther. 2005 312(2):492-501. Callahan, S. M., Wonganan, P., Obenauer-Kutner, L. J., Sutjipto, S., Dekker, J.D., and Croyle, M. A. Controlled Inactivation of Recombinant Viruses with Vitamin B2 J. Virol. Meth. 2008 148(1-2):132-145. Patel, A., Zhang, Y., Croyle, M., Gray, M., Strong, J., Feldmann, H., Wilson, J.M. and Kobinger, G.P. Mucosal Delivery of Adenovirus-Based Vaccine Protects Against Ebola Virus Infection. 2007 J. Infect. Dis. 196(Suppl. 2):S413-S420. Le, H. T., Yu, Q. C., Wilson, J. M. and Croyle, M. A. Utility of PEGylated Recombinant Adeno-Associated Viruses for Gene Transfer. J. Control. Rel. 2005 108(1):161-177. Croyle, M. A., Le, H., Linse, K., Ming, X., Toietta, G., Beaudet, A. and Pastore, L. PEGylated Helper-Dependent Adenoviral Vectors: Highly Efficient Vectors with an Enhanced Safety Profile. Gene Ther. 2005 12(7):579-588. Croyle, M. A. Callahan, S. M., Auricchio, A., Schumer, G., Wilson, J. M., Linse, K., Brunner, L. J. and Kobinger, G. P. PEGylation of a Vesicular Stomatitis Virus G Pseudotyped Lentiviral Vector Prevents Inactivation in Serum. J. Virol. 2004 78(2):912-921. Croyle, M. A. Callahan, S. M., Auricchio, A., Schumer, G., Wilson, J. M., Linse, K., Brunner, L. J. and Kobinger, G. P.
PEGylation of a Vesicular Stomatitis Virus G Pseudotyped Lentiviral Vector Prevents Inactivation in Serum. J. Virol. 2003 78(2):912-921.
Yu QC, Ma X, Croyle M, Qu G, Huang J, Gao GP, Hughes J, Wilson JM. Electron microscopic evaluation of vector quality for gene therapy. Microsc Microanal (2000) 6:858-859
Croyle, M. A., Anderson, D. J., Roessler, B. J., and Amidon, G. L. Development of a Highly Efficient Purification Process for Recombinant Adenoviral Vectors for Oral Gene Delivery. Pharm. Dev. Technol. 3(3) (1998) 365-372. Kobinger, G.P., Croyle, M.A., and Feldmann, H.. Filoviruses. In: Vaccines for Biodefense and Emerging and Neglected Diseases, Eds. Barrett, A. D. T. and Stanberry, L. R. New York: Elsevier 2008 pp.323-336. Croyle, M.A. Gene Therapy. In: Crommelin, D. Sindelar, E. and Meibohm B., Eds. Pharmaceutical Biotechnology: Fundamentals and Applications. 3rd Ed. New York: Informa healthcare. 2008 pp:175-210.
More information about Dr. Croyle > Background & Training > Teaching Interests > Affiliations & Related Links > Recent Publications > Lab Group > News > Return to Dr. Croyle's Home Page | ||
Division Information
Mailing Address:
Pharmaceutics Division
College of Pharmacy
The University of Texas
at Austin
2409 University Ave.
Stop A1900
Austin, TX, USA
78712-1113
Email Address: pharmacy
@www.utexas.edu
Phone:
1-512-471-7182
Enhancing drug-delivery technologies can help in curing and treating diseases such as cancer, cardiovascular diseases, diabetes, fungal, respiratory and infectious diseases and treatment after organ transplants to prevent rejection.